RADIAL submitted in CTIS

Utrecht, March 28, 2022

We are pleased to inform you that we have submitted the RADIAL study under the new Clinical Trial Regulation using CTIS for the participating EU countries Germany, Poland, Italy, Spain and Denmark on March 28. This is an important milestone achieved for Radial. This application was one of the 25 applications done so far in CTIS.

We would like to take the opportunity to thank everyone involved for all the work done to achieve this milestone.


This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831458. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Notes for editors – not for publication
If you would like more information, please contact the spokesperson at the UMC Utrecht.
Joris Prinssen: +31 6 2571 0234